Skip to main navigation Skip to search Skip to main content

The survival of B cells is compromised in kidney disease

  • Doureradjou Peroumal
  • , Chetan V. Jawale
  • , Wonseok Choi
  • , Hossein Rahimi
  • , Danielle Antos
  • , De Dong Li
  • , Shuxia Wang
  • , Godhev K. Manakkat Vijay
  • , Isha Mehta
  • , Raymond West
  • , Muthusamy Thangaraju
  • , Thomas D. Nolin
  • , Jishnu Das
  • , John F. Alcorn
  • , Partha S. Biswas
  • University of Pittsburgh
  • Stony Brook University
  • Augusta University

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Antibody-mediated protection against pathogens is crucial to a healthy life. However, the recent SARS-CoV-2 pandemic has shown that pre-existing comorbid conditions including kidney disease account for compromised humoral immunity to infections. Individuals with kidney disease are not only susceptible to infections but also exhibit poor vaccine-induced antibody response. Using multiple mouse models of kidney disease, we demonstrate that renal dysfunction inhibits germinal center (GC) response against T-dependent antigens. GC B cells exhibit increased apoptosis in kidney disease. Uremic toxin hippuric acid drives loss of mitochondrial membrane potential, leading to increased apoptosis of GC B cells in a G-protein–coupled receptor 109A dependent manner. Finally, GC B cells and antibody titer are diminished in mice with kidney disease following influenza virus infection, a major cause of mortality in individuals with renal disorders. These results provide a mechanistic understanding of how renal dysfunction suppresses humoral immunity in patients with kidney disease.

Original languageEnglish
Article number10842
JournalNature Communications
Volume15
Issue number1
DOIs
StatePublished - Dec 2024

Fingerprint

Dive into the research topics of 'The survival of B cells is compromised in kidney disease'. Together they form a unique fingerprint.

Cite this